Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MIRM market cap is 2.24B. The company's latest EPS is USD -1.7942 and P/E is -25.48.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 37.5M | 47.73M | 69.55M | 90.38M | 99.41M |
| Operating Income | -24.27M | -25.15M | -32.59M | -12.68M | -24.22M |
| Net Income | -74.04M | -23.59M | -35.66M | -14.24M | -23.79M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 19.14M | 77.06M | 186.37M | 336.89M |
| Operating Income | -104.3M | -173.41M | -131.22M | -109.15M | -87.61M |
| Net Income | -103.27M | -83.99M | -135.67M | -163.42M | -87.94M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 443.59M | 650.64M | 646.62M | 667.89M | 670.75M |
| Total Liabilities | 364.98M | 381.56M | 397.95M | 435.87M | 445.11M |
| Total Equity | 78.61M | 269.08M | 248.67M | 232.02M | 225.64M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 240.86M | 294.65M | 352.91M | 646.62M | 670.75M |
| Total Liabilities | 68.77M | 174.44M | 210.87M | 397.95M | 445.11M |
| Total Equity | 172.1M | 120.21M | 142.04M | 248.67M | 225.64M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.11M | -54.33M | -70.94M | 15.39M | 10.33M |
| Investing | 77.56M | -105.2M | -107.2M | -90.77M | -90.13M |
| Financing | 127.69M | 334.82M | 336.6M | 12.36M | 17.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -89.08M | -132.76M | -120.14M | -70.94M | 10.33M |
| Investing | 37.87M | 48.55M | 7.7M | -107.2M | -90.13M |
| Financing | 181.29M | 73.47M | 109.09M | 336.6M | 17.7M |
| Market Cap | 2.24B |
| Price to Earnings Ratio | -25.48 |
| Price to Sales Ratio | 6.65 |
| Price to Cash Ratio | 10.07 |
| Price to Book Ratio | 9.93 |
| Dividend Yield | - |
| Shares Outstanding | 49.01M |
| Average Volume (1 week) | 629.99k |
| Average Volume (1 Month) | 561.19k |
| 52 Week Change | 54.37% |
| 52 Week High | 54.234 |
| 52 Week Low | 23.14 |
| Spread (Intraday) | 0.09 (0.2%) |
| Company Name | Mirum Pharmaceuticals Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
